Sign Out
Administration of Etoricoxib at single doses up to 500 mg and multiple doses up to 150 mg/day for 21 days did not result in significant toxicity. There have reports of acute overdosage with Etoricoxib, although adverse experiences were not reported in the majority of cases. The most frequently observed adverse experiences were consistent with the safety profile for Etoricoxib (e.g. gastrointestinal events, renovascular events).
In the event of overdoses it is reasonable to employ the usual supportive measure e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring and institute supportive therapy, if required.
Etoricoxib is not dialyzable by hemodialysis; it is not known whether Etoricoxib is dialyzable by peritoneal dialysis.
